Progress in and priorities for implementing the regional plans for the health sector response to HIV and hepatitis, Dr Masoud Dara, Acting Director, Communicable Diseases Department (69th session of the WHO Regional Committee for Europe)
Call Girls Varanasi Just Call 8250077686 Top Class Call Girl Service Available
Progress in and priorities for implementing the regional plans for the health sector response to HIV and hepatitis
1. (1)
19 September 2019
Dr Masoud Dara
Acting Director, Communicable Diseases Department
Progress in and priorities for implementing
the regional plans for the health sector
response to HIV and hepatitis
2. (2)
74 76
82
62
67 66
83 81 84
0
10
20
30
40
50
60
70
80
90
100
Percentage of people living with HIV
who know their status
Percentage of people who know their
status who are on ART
Percentage of people on ART
who achieve viral suppression
Progress towards the HIV 90-90-90 targets by 2020
WHO European Region
Source: Global AIDS Monitoring, 2017
3. (3)
Political commitment to end AIDS
Ministerial policy dialogue on HIV and related comorbidities in
eastern Europe and central Asia, 23 July 2018, Amsterdam, Netherlands
Revamped commitment to end the HIV epidemic by 2030 and achieve SDG target 3.3
4. (4)
Country HIV roadmaps and sharing of good practices
• Compendium of good HIV practices in the
European Region: 52 examples from 33
Member States
• HIV roadmaps to accelerate the progress
towards the 2020 targets in 14 countries
• Essential package of HIV services for migrants
in central Asia
• Compendium of good hepatitis practices in
development: so far 20 examples from
13 countries
• Online repository of good practices in
development
5. (5)
Regional mechanisms to provide country support and
validate elimination efforts
• HIV Treatment Reference Group (TRG),
August 2018
• European Laboratory Initiative (ELI)
expanded to cover HIV and hepatitis,
November 2018
• Regional Validation Committee (RVC) for
elimination of MTCT of HIV and syphilis,
February 2019
• Regional Collaborating Committee on
Accelerated Response to Tuberculosis,
HIV and Viral Hepatitis (RCC-THV),
April 2019
eMTCT RVC
TRG ELI
RCC-THV
6. (6)
Country hepatitis plans development
The number of countries in the
European Region with national
hepatitis plans increased from
13 (in 2013)
33 (in 2019)
Endorsed hepatitis action plans (33 countries)
Developing hepatitis action plans (13 countries)
7. (7)
First Regional Consultation on Viral Hepatitis in the WHO European Region:
Progress on the Way to Elimination
Tbilisi, Georgia, February 2019
8. (8)
Way forward within the framework of universal health coverage
1. Prioritize preventive measures for key populations, including HIV
pre-exposure prophylaxis (PrEP)
2. Decentralize and simplify testing for HIV and hepatitis
3. Optimize treatment regimens and scale up early treatment
and full care
Fully finance and implement the national action plans
Reinforce health systems and people-centred integrated care
Strengthen strategic information and monitoring response
9. (9)
WHO Regional Office for Europe
UN City
Marmorvej 51
DK-2100 Copenhagen Ø
Denmark
www.euro.who.int
Thank you
Editor's Notes
Progress has been made in the HIV cascade where we have reached 82% PLHIV diagnosed, 66% of those diagnosed on ART and 84% of those on ART achieving viral suppression
HIV Treat All policy has been widely adopted. The Region will have to address late diagnoses and linkage loss between diagnosis and antiretroviral treatment.
To address the rising trends of new HIV diagnosis in the Region and in particular in EECA, on the Regional Director intiative, a Ministerial policy dialogue on HIV was organized by WHO in cooperation with the Government of the Netherlands and the Joint United Nations Programme on HIV/AIDS (UNAIDS) in Amsterdam in July 2018.
The meeting registered the highest ministerial attendance ever recorded in such a meeting with 11 ministers or deputy ministers of health attending.
Participants expressed governments’ firm commitment to scale up efforts to implement the WHO Regional Plan on health sector response to HIV and achieve the 2020 targets.
The essential care package for HIV among migrants outlines a set of recommendations to national governments on the adoption of HIV prevention, testing, treatment and access to care for migrants, especially labour migrants and people moving within and between the central Asian countries.
The Regional Validation Committee for elimination of MTCT of HIV and syphilis was established in February 2019 to support the validation of eMTCT HIV and syphilis in countries of the region. eMTCT HIV and/or CS was achieved in 3 countries and several other countries are in the pipeline.
The HIV Treatment reference group was established in 2019 to strengthen the capacity of Member States in the WHO European Region on HIV treatment and care
WHO/Europe established the European Laboratory Initiative (ELI) in 2012, in collaboration with the Global Laboratory Initiative (GLI), to strengthen laboratory capacities for accurate diagnosis and early detection of tuberculosis (TB) and drug-resistant TB in the WHO European Region. In 2018, ELI’s mission was expanded to cover testing, diagnosis, monitoring and laboratory needs also for TB/HIV coinfection, HIV and viral hepatitis, with the ultimate objective of strengthening and making more efficient the response for all 3 diseases in the WHO European Region
The RCC-THV is a European platform for interactive exchange of information and strengthened involvement of national and international partners, including civil society organizations, in the prevention, diagnosis, treatment and care of tuberculosis (TB), HIV and viral hepatitis, hosted by WHO/Europe.
The First Regional Consultation on Viral Hepatitis in the WHO European Region: Progress on the Way to Elimination was organized in Tbilisi, Georgia, in February 2019 to share progress, challenges and good practices in the response to viral hepatitis according to the Action plan for the health sector response to viral hepatitis in the Region and to present the latest WHO recommendations for viral hepatitis according to the Global Health Sector Strategies and the Thirteenth General Programme of Work.
Special emphasis was made on national planning for viral hepatitis and framework for monitoring the progress of National plans.
From high coverage of hepatitis B immunization, to increased access to diagnosis and treatment and decriminalization of drugs, the examples of success in the WHO European Region set a high, yet achievable bar to all countries.